Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3154)
All Articles published online
|
Feb 14, 2009 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Alavian SM. A shield against a monster: Hepatitis C in hemodialysis patients. World J Gastroenterol 2009; 15(6): 641-646 [PMID: 19222088 DOI: 10.3748/wjg.15.641] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i6/641.htm |
| Number | Citing Articles |
| 1 |
A. Slack, A. Yeoman, J. Wendon. Intensive Care Medicine. 2010; : 349 doi: 10.1007/978-1-4419-5562-3_33
|
| 2 |
Marco Lombardi. Making the Point on Hepatitis B and C in Dialysis: Role of Patients' Isolation. Giornale di Tecniche Nefrologiche e Dialitiche 2014; 26(4): 321 doi: 10.5301/GTND.2014.12396
|
| 3 |
S Datta, N Goel, C Wattal. Utility of routine real time quantitative PCR monitoring of HCV infection in haemodialysis patients. Indian Journal of Medical Microbiology 2015; 33: S106 doi: 10.4103/0255-0857.148832
|
| 4 |
Tatjana Vilibic-Cavlek, Jasmina Kucinar, Bernard Kaic, Maja Vilibic, Nenad Pandak, Ljubo Barbic, Vladimir Stevanovic, Jasmina Vranes. Epidemiology of hepatitis C in Croatia in the European context. World Journal of Gastroenterology 2015; 21(32): 9476-9493 doi: 10.3748/wjg.v21.i32.9476
|
| 5 |
Seyed-Moayed Alavian, Seyed-Vahid Tabatabaei, Nastaran Mahboobi. Epidemiology and risk factors of HCV infection among hemodialysis patients in countries of the Eastern Mediterranean Regional Office of WHO (EMRO): a quantitative review of literature. Journal of Public Health 2011; 19(2): 191 doi: 10.1007/s10389-010-0366-2
|
| 6 |
Ignatius Y. S. Tang, Natasha Walzer, Nidhi Aggarwal, Ivo Tzvetanov, Scott Cotler, Enrico Benedetti. Management of the Kidney Transplant Patient with Chronic Hepatitis C Infection. International Journal of Nephrology 2011; 2011: 1 doi: 10.4061/2011/245823
|
| 7 |
Meryem Güvenir, Emrah Guler, Deren Oygar, Ahmet Behlul, Kaya Suer. Evaluating the Prevalence of HBV, HCV, and HIV in Hemodialysis Patients in North Cyprus. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.84699
|
| 8 |
A. Slack, A. Yeoman, J. Wendon. Yearbook of Intensive Care and Emergency Medicine 2010. Yearbook of Intensive Care and Emergency Medicine 2010; 2010: 349 doi: 10.1007/978-3-642-10286-8_33
|
| 9 |
Hao-Hsi Kao, Kuo-Su Chen, Chih-Lang Lin, Jia-Jang Chang, Chien-Hung Lee. Utilization of Signal-to-Cutoff Ratio of Hepatitis C Virus Antibody Assay in Predicting HCV Viremia among Hemodialysis Patients. Nephron 2015; 130(2): 127 doi: 10.1159/000430988
|
| 10 |
Yue-Cheng Yu, Yue Wang, Chang-Lun He, Mao-Rong Wang, Yu-Ming Wang. Management of hepatitis C virus infection in hemodialysis patients. World Journal of Hepatology 2014; 6(6): 419-425 doi: 10.4254/wjh.v6.i6.419
|
| 11 |
Rising burden of Hepatitis C Virus in hemodialysis patients. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-438
|
| 12 |
Seyed Moayed Alavian, Kamran Bagheri Lankarani, Ala I. Sharara. Treatment of Chronic HCV in Special Populations: Thalassemia, Hemophilia, and Hemodialysis Patients. Current Hepatitis Reports 2012; 11(4): 256 doi: 10.1007/s11901-012-0147-1
|
| 13 |
Marzieh Jamalidoust, Maryam Eskandari, Mazyar Ziyaeyan. Prevalence of Hepatitis C Infection and its Genotypes in Suspected Hemodialysis Patients, Southwest of Iran. Jundishapur Journal of Microbiology 2021; 14(11) doi: 10.5812/jjm.118591
|
| 14 |
Dimie Aruna, Abubakar Adereti, Easley A. Munir. Prevalence of hepatitis C virus infection among hemodialysis patients: cohort study. American Journal of BioMedicine 2023; 11(1): 36 doi: 10.18081/2333-5106/2023.11/36
|
| 15 |
Mary Anne Bobinski. Health Care–Associated Hepatitis B and C Viruses: Legal Aspects. Clinics in Liver Disease 2010; 14(1): 105 doi: 10.1016/j.cld.2009.11.002
|
| 16 |
Seyyed Moayed Alavian. Seronegative anti‐hepatitis C virus antibody in hemodialysis patients. Hemodialysis International 2013; 17(2): 328 doi: 10.1111/j.1542-4758.2012.00738.x
|
| 17 |
Sohail Akhtar, Jamal Abdul Nasir, Muhammad Usman, Aqsa Sarwar, Rizwana Majeed, Baki Billah, Ming-Lung Yu. The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: A systematic review and meta-analysis. PLOS ONE 2020; 15(5): e0232931 doi: 10.1371/journal.pone.0232931
|
| 18 |
Seyed Moayed Alavian. An Unbelievable Fact on “Dialysis Centers Without Hepatitis C Infection”. Nephro-Urology Monthly 2014; 6(2) doi: 10.5812/numonthly.17998
|
| 19 |
Soheil Ashkani-Esfahani, Seyed Moayed Alavian, Mohammad Salehi-Marzijarani. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis. World Journal of Gastroenterology 2017; 23(1): 151-166 doi: 10.3748/wjg.v23.i1.151
|
| 20 |
Seyed Moayed Alavian. Occult Hepatitis B and Hemodialysis Patients Need Increased Precautions With the Interpretation of Results. Therapeutic Apheresis and Dialysis 2010; 14(6): 609 doi: 10.1111/j.1744-9987.2010.00878.x
|